Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111940005 | 11194000 | 5 | F | 20150511 | 20160812 | 20150616 | 20160815 | EXP | JP-ROCHE-1594876 | ROCHE | 71.00 | YR | M | Y | 38.00000 | KG | 20160815 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111940005 | 11194000 | 1 | SS | G-Lasta | PEGFILGRASTIM | 1 | Subcutaneous | TOTAL 3 COURSE | Y | 0 | 3.6 | MG | Q3W | ||||||
| 111940005 | 11194000 | 2 | SS | G-Lasta | PEGFILGRASTIM | 1 | Y | 0 | |||||||||||
| 111940005 | 11194000 | 3 | PS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | TOTAL 3 COURSE | Y | 103705 | 500 | MG | SOLUTION FOR INFUSION | ||||||
| 111940005 | 11194000 | 4 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | Y | 103705 | 375 | MG/M**2 | SOLUTION FOR INFUSION | |||||||
| 111940005 | 11194000 | 5 | SS | ADRIACIN | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous bolus | TOTAL 3 COURSE | Y | 0 | 50 | MG | Q3W | ||||||
| 111940005 | 11194000 | 6 | SS | ONCOVIN | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | TOTAL 3 COURSE | Y | 0 | 1.5 | MG | Q3W | ||||||
| 111940005 | 11194000 | 7 | SS | ENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | TOTAL 3 COURSE | Y | 0 | 800 | MG | Q3W | ||||||
| 111940005 | 11194000 | 8 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | TOTAL 3 COURSE | Y | 0 | |||||||||
| 111940005 | 11194000 | 9 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111940005 | 11194000 | 1 | Colony stimulating factor prophylaxis |
| 111940005 | 11194000 | 2 | Prophylaxis |
| 111940005 | 11194000 | 3 | Diffuse large B-cell lymphoma |
| 111940005 | 11194000 | 5 | Diffuse large B-cell lymphoma |
| 111940005 | 11194000 | 6 | Diffuse large B-cell lymphoma |
| 111940005 | 11194000 | 7 | Diffuse large B-cell lymphoma |
| 111940005 | 11194000 | 8 | Diffuse large B-cell lymphoma |
| 111940005 | 11194000 | 9 | Interstitial lung disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111940005 | 11194000 | HO |
| 111940005 | 11194000 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111940005 | 11194000 | Interstitial lung disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111940005 | 11194000 | 1 | 20150317 | 20150428 | 0 | |
| 111940005 | 11194000 | 3 | 20150316 | 20150427 | 0 | |
| 111940005 | 11194000 | 5 | 20150316 | 20150427 | 0 | |
| 111940005 | 11194000 | 6 | 20150316 | 20150427 | 0 | |
| 111940005 | 11194000 | 7 | 20150316 | 20150427 | 0 | |
| 111940005 | 11194000 | 8 | 20150316 | 20150427 | 0 |